169 related articles for article (PubMed ID: 26530813)
1. The arterial tumor enhancement pattern on contrast-enhanced computed tomography is associated with primary cancer death after radiofrequency ablation for small hepatocellular carcinoma.
Shimizu R; Tamai H; Mori Y; Shingaki N; Maeshima S; Nuta J; Maeda Y; Moribata K; Muraki Y; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
Hepatol Int; 2016 Mar; 10(2):328-39. PubMed ID: 26530813
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation.
Kawamura Y; Ikeda K; Seko Y; Hosaka T; Kobayashi M; Saitoh S; Kumada H
AJR Am J Roentgenol; 2011 Oct; 197(4):W665-73. PubMed ID: 21940538
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of hepatocellular carcinoma tumor vascularity using contrast-enhanced ultrasonography as a predictor for local recurrence following radiofrequency ablation.
Ishii T; Numata K; Hao Y; Doba N; Hara K; Kondo M; Tanaka K; Maeda S
Eur J Radiol; 2017 Apr; 89():234-241. PubMed ID: 28034569
[TBL] [Abstract][Full Text] [Related]
4. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990
[TBL] [Abstract][Full Text] [Related]
5. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
7. Arterial enhancement of hepatocellular carcinoma before radiofrequency ablation as a predictor of postablation local tumor progression.
Park Y; Kim YS; Rhim H; Lim HK; Choi D; Lee WJ
AJR Am J Roentgenol; 2009 Sep; 193(3):757-63. PubMed ID: 19696290
[TBL] [Abstract][Full Text] [Related]
8. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.
Ng KK; Poon RT; Lo CM; Yuen J; Tso WK; Fan ST
J Gastrointest Surg; 2008 Jan; 12(1):183-91. PubMed ID: 17874276
[TBL] [Abstract][Full Text] [Related]
9. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT.
Chopra S; Dodd GD; Chintapalli KN; Leyendecker JR; Karahan OI; Rhim H
AJR Am J Roentgenol; 2001 Aug; 177(2):381-7. PubMed ID: 11461868
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence.
Murakami T; Ishimaru H; Sakamoto I; Uetani M; Matsuoka Y; Daikoku M; Honda S; Koshiishi T; Fujimoto T
Cardiovasc Intervent Radiol; 2007; 30(4):696-704. PubMed ID: 17497071
[TBL] [Abstract][Full Text] [Related]
11. Prediction of poorly differentiated hepatocellular carcinoma using contrast computed tomography.
Nakachi K; Tamai H; Mori Y; Shingaki N; Moribata K; Deguchi H; Ueda K; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
Cancer Imaging; 2014 Apr; 14(1):7. PubMed ID: 25608454
[TBL] [Abstract][Full Text] [Related]
12. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency Ablation of Hepatic Tumor: Subjective Assessment of the Perilesional Vascular Network on Contrast-Enhanced Computed Tomography Before and After Ablation Can Reliably Predict the Risk of Local Recurrence.
Yedururi S; Terpenning S; Gupta S; Fox P; Martin SS; Conrad C; Loyer EM
J Comput Assist Tomogr; 2017; 41(4):607-613. PubMed ID: 28722702
[TBL] [Abstract][Full Text] [Related]
14. Advantages of Laparoscopic Radiofrequency Ablation Over Percutaneous Radiofrequency Ablation in Hepatocellular Carcinoma.
Eun HS; Lee BS; Kwon IS; Yun GY; Lee ES; Joo JS; Sung JK; Moon HS; Kang SH; Kim JS; Shin HJ; Kim TK; Chun K; Kim SH
Dig Dis Sci; 2017 Sep; 62(9):2586-2600. PubMed ID: 28744835
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
[TBL] [Abstract][Full Text] [Related]
16. Comparison of percutaneous radiofrequency ablation and CyberKnife(®) for initial solitary hepatocellular carcinoma: A pilot study.
Shiozawa K; Watanabe M; Ikehara T; Matsukiyo Y; Kogame M; Kishimoto Y; Okubo Y; Makino H; Tsukamoto N; Igarashi Y; Sumino Y
World J Gastroenterol; 2015 Dec; 21(48):13490-9. PubMed ID: 26730160
[TBL] [Abstract][Full Text] [Related]
17. Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.
Mikami S; Tateishi R; Akahane M; Asaoka Y; Kondo Y; Goto T; Shiina S; Yoshida H; Koike K
J Vasc Interv Radiol; 2012 Oct; 23(10):1269-75. PubMed ID: 22999746
[TBL] [Abstract][Full Text] [Related]
18. Kupffer Imaging by Contrast-Enhanced Sonography With Perfluorobutane Microbubbles Is Associated With Outcomes After Radiofrequency Ablation of Hepatocellular Carcinoma.
Nuta J; Tamai H; Mori Y; Shingaki N; Maeshima S; Shimizu R; Maeda Y; Moribata K; Niwa T; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
J Ultrasound Med; 2016 Feb; 35(2):359-71. PubMed ID: 26782163
[TBL] [Abstract][Full Text] [Related]
19. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O
J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908
[TBL] [Abstract][Full Text] [Related]
20. Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation.
Sohn W; Paik YH; Lee MW; Rhim H; Lim HK; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Scand J Gastroenterol; 2014 Mar; 49(3):373-80. PubMed ID: 24354931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]